VRTX - Vertex Pharmaceuticals Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts22222223
Avg. Estimate1.021.083.794.64
Low Estimate0.880.893.463.38
High Estimate1.131.284.116.02
Year Ago EPS0.530.611.953.79
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts20202123
Avg. Estimate789.12M824.85M3.01B3.55B
Low Estimate771.79M790M2.96B3.05B
High Estimate819.8M876.66M3.09B3.87B
Year Ago Sales551.87M622.63M2.17B3.01B
Sales Growth (year/est)43.00%32.50%38.30%18.20%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.0.310.530.630.75
EPS Actual0.530.610.760.94
Difference0.220.080.130.19
Surprise %71.00%15.10%20.60%25.30%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate1.021.083.794.64
7 Days Ago1.011.083.784.62
30 Days Ago1.011.083.774.7
60 Days Ago1.011.083.774.68
90 Days Ago0.830.93.24.59
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days2221
Up Last 30 Days4452
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days111N/A
Growth EstimatesVRTXIndustrySectorS&P 500
Current Qtr.92.50%N/AN/A0.48
Next Qtr.77.00%N/AN/A0.40
Current Year94.40%N/AN/A0.21
Next Year22.40%N/AN/A0.10
Next 5 Years (per annum)51.63%N/AN/A0.11
Past 5 Years (per annum)55.90%N/AN/AN/A